55 results
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:00am
or warrants to purchase or otherwise acquire (whether immediately, during specified times, upon the satisfaction of any conditions or otherwise) any … in the name of the applicable Holder; (D) upon satisfaction of any applicable requirements of the Delaware General Corporation Law, the Certificate
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
, on April 15, 2024, subject to the satisfaction or waiver of the conditions set forth in Section 1.3 (other than those conditions … that by their nature are to be satisfied at the Closing, but subject to their satisfaction); (the date on which the Closing actually occurs, the “Closing Date”).
(b
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
capital, and for general corporate purposes. The transaction is expected to close on or about April 15, 2024, subject to the satisfaction of customary … . The Preferred Stock will vote with the common stock on an as-converted basis, subject to satisfaction of certain antitrust-related conditions.
Holders
8-K
EX-10.1
ghu2sg6
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.2
4p81qmyip3rffc5pxz
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.4
7ymx9n1
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
ff9 2mpal
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
gd7js
15 Sep 22
Other Events
4:02pm
S-3
EX-1.2
pqutmgqhahgyxpqn
2 Nov 21
Shelf registration
5:21pm